Stocktoria

Aardvark Therapeutics, Inc. AARD

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-02-13

Aardvark Therapeutics, Inc. statistics & valuation

Market cap$104.5M
P / B1.0×
Return on equity-54.0%
Return on capital-58.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-54.00% 20242025
Shares outstanding
4.1M 21.8M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-26.60% -49.10% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$5.15 -$2.93 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-49.1%-26.6%
Return on equity-54.0%37.7%
Current ratio10.6115.05

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.